FINAL EXAM
DECEMBER 2020
--- Content provided by FirstRanker.com ---
NUCLEAR MEDICINE
PAPER-II
Time: 3 hours NM/D/20/24/II
Max. Marks: 100
--- Content provided by FirstRanker.com ---
Important Instructions:
- You are provided with 5 answer sheet booklets. Each individual answer sheet booklet consists of 10 pages excluding the covering jackets.
- Answers to all the questions must be attempted within these 5 answer sheet booklets which must be later tagged together at the end of the exam.
- No additional supplementary answer sheet booklet will be provided.
- Attempt all questions in order.
- Each question carries 10 marks.
- Read the question carefully and answer to the point neatly and legibly.
- Do not leave any blank pages between two answers.
- Indicate the question number correctly for the answer in the margin space.
- Answer all the parts of a single question together.
- Start the answer to a question on a fresh page or leave adequate space between two answers.
- Draw table/diagrams/flowcharts wherever appropriate.
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
Write short notes on:
- a) 18F-FET vs. 18F-FDOPA in glial tumors. 5+5
b) Why F18 Sodium Fluoride bone scan is not able to replace Tc99m MDP bone scan? - a) LAL test. 5+5
b) Swipe test. - What are the principles radionuclide generators in nuclear medicine? 7+3
Describe the various PET radionuclide producing generators. - Name the various available bone pain palliation agents for the Indian patients. What are the emerging radiopharmaceuticals for similar applications? 6+4
- a) 18F-Choline vs. 99mTc-Sestamibi. 5+5
b) 18F-Fluciclovine vs. 68Ga-PSMA11. - Name useful alpha-emitters currently available and their characteristics. 7+3
Why in India we are not able to produce such radionuclides? - Describe various bi-functional chelators. Justify how twenty-first century radiochemistry has been changed due to such chelants. 5+5
- Name various peptide-based radiopharmaceuticals and describe one in details. 5+5
- a) Imaging agents for insulinoma. 5+5
b) Imaging agents for Neuroblastoma. - Describe the imaging artefacts in SPECT and SPECT/CT. How will you avoid or minimize them? 7+3
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
--- Content provided by FirstRanker.com ---
This download link is referred from the post: DNB 2020 Dec Previous Question Papers-(Diplomate of National Board) Under NBE
--- Content provided by FirstRanker.com ---